These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
701 related items for PubMed ID: 17463082
21. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y. Nature; 2005 Mar 31; 434(7033):652-8. PubMed ID: 15800626 [Abstract] [Full Text] [Related]
22. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Lühder F, Gold R. Brain; 2010 Aug 31; 133(Pt 8):2248-63. PubMed ID: 20826430 [Abstract] [Full Text] [Related]
24. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C. J Exp Med; 2006 Feb 20; 203(2):425-35. PubMed ID: 16476770 [Abstract] [Full Text] [Related]
25. [Neuronal injury in multiple sclerosis]. Correale J, Meli F, Ysrraelit C. Medicina (B Aires); 2006 Feb 20; 66(5):472-85. PubMed ID: 17137182 [Abstract] [Full Text] [Related]
26. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD. J Neuropathol Exp Neurol; 2002 Jan 20; 61(1):23-32. PubMed ID: 11829341 [Abstract] [Full Text] [Related]
27. Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis. Warne J, Pryce G, Hill JM, Shi X, Lennerås F, Puentes F, Kip M, Hilditch L, Walker P, Simone MI, Chan AW, Towers GJ, Coker AR, Duchen MR, Szabadkai G, Baker D, Selwood DL. J Biol Chem; 2016 Feb 26; 291(9):4356-73. PubMed ID: 26679998 [Abstract] [Full Text] [Related]
28. 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity. Wang P, Wang ZW, Lin FH, Han Z, Hou ST, Zheng RY. Biochem Biophys Res Commun; 2011 Mar 04; 406(1):152-7. PubMed ID: 21303658 [Abstract] [Full Text] [Related]
29. Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis. Honorat JA, Kinoshita M, Okuno T, Takata K, Koda T, Tada S, Shirakura T, Fujimura H, Mochizuki H, Sakoda S, Nakatsuji Y. PLoS One; 2013 Mar 04; 8(8):e71329. PubMed ID: 23951137 [Abstract] [Full Text] [Related]
30. Mechanisms of axonal degeneration in EAE--lessons from CNTF and MHC I knockout mice. Linker RA, Sendtner M, Gold R. J Neurol Sci; 2005 Jun 15; 233(1-2):167-72. PubMed ID: 15949503 [Abstract] [Full Text] [Related]
32. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration. van Strien ME, de Vries HE, Chrobok NL, Bol JGJM, Breve JJP, van der Pol SMP, Kooij G, van Buul JD, Karpuj M, Steinman L, Wilhelmus MM, Sestito C, Drukarch B, Van Dam AM. Brain Behav Immun; 2015 Nov 15; 50():141-154. PubMed ID: 26133787 [Abstract] [Full Text] [Related]
33. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis. Andrews HE, Nichols PP, Bates D, Turnbull DM. Med Hypotheses; 2005 Nov 15; 64(4):669-77. PubMed ID: 15694681 [Abstract] [Full Text] [Related]
34. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation. Madsen PM, Pinto M, Patel S, McCarthy S, Gao H, Taherian M, Karmally S, Pereira CV, Dvoriantchikova G, Ivanov D, Tanaka KF, Moraes CT, Brambilla R. J Neurosci; 2017 Oct 18; 37(42):10185-10199. PubMed ID: 28931570 [Abstract] [Full Text] [Related]
38. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, Lavon I, Milonas I, Karussis D, Abramsky O, Ben-Hur T. Exp Neurol; 2006 Apr 18; 198(2):275-84. PubMed ID: 16472805 [Abstract] [Full Text] [Related]